| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1681 | 2015 |
| New insights into the genetic etiology of Alzheimer’s disease and related dementias C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ... Nature genetics 54 (4), 412-436, 2022 | 1532 | 2022 |
| TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis G Kleinberger, Y Yamanishi, M Suárez-Calvet, E Czirr, E Lohmann, ... Science translational medicine 6 (243), 243ra86-243ra86, 2014 | 816 | 2014 |
| sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers M Suárez‐Calvet, G Kleinberger, MÁ Araque Caballero, M Brendel, ... EMBO molecular medicine 8 (5), 466-476, 2016 | 511 | 2016 |
| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 401 | 2013 |
| Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture R Chia, MS Sabir, S Bandres-Ciga, S Saez-Atienzar, RH Reynolds, ... Nature genetics 53 (3), 294-303, 2021 | 300 | 2021 |
| Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World … P Lewczuk, P Riederer, SE O’bryant, MM Verbeek, B Dubois, PJ Visser, ... The world journal of biological psychiatry 19 (4), 244-328, 2018 | 283 | 2018 |
| Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study J Fortea, E Vilaplana, M Carmona-Iragui, B Benejam, L Videla, I Barroeta, ... The Lancet 395 (10242), 1988-1997, 2020 | 281 | 2020 |
| The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk Y Deming, F Filipello, F Cignarella, C Cantoni, S Hsu, R Mikesell, Z Li, ... Science translational medicine 11 (505), eaau2291, 2019 | 260 | 2019 |
| Performance and complications of lumbar puncture in memory clinics: results of the multicenter lumbar puncture feasibility study FH Duits, P Martinez‐Lage, C Paquet, S Engelborghs, A Lleo, L Hausner, ... Alzheimer's & dementia 12 (2), 154-163, 2016 | 260 | 2016 |
| Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ... Nature communications 12 (1), 3417, 2021 | 249 | 2021 |
| Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease P Podlesniy, J Figueiro‐Silva, A Llado, A Antonell, R Sanchez‐Valle, ... Annals of neurology 74 (5), 655-668, 2013 | 227 | 2013 |
| Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology NJ Ashton, WS Brum, G Di Molfetta, AL Benedet, B Arslan, E Jonaitis, ... JAMA neurology 81 (3), 255-263, 2024 | 214 | 2024 |
| Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer's disease cerebrospinal fluid A Lleó, R Núñez-Llaves, D Alcolea, C Chiva, D Balateu-Paños, ... Molecular & Cellular Proteomics 18 (3), 546-560, 2019 | 197 | 2019 |
| Reduced slow-wave sleep is associated with high cerebrospinal fluid Aβ42 levels in cognitively normal elderly AW Varga, ME Wohlleber, S Giménez, S Romero, JF Alonso, EL Ducca, ... Sleep 39 (11), 2041-2048, 2016 | 194 | 2016 |
| Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study J Fortea, M Carmona-Iragui, B Benejam, S Fernández, L Videla, ... The Lancet Neurology 17 (10), 860-869, 2018 | 191 | 2018 |
| Association of cerebral amyloid-β aggregation with cognitive functioning in persons without dementia WJ Jansen, R Ossenkoppele, BM Tijms, AM Fagan, O Hansson, ... JAMA psychiatry 75 (1), 84-95, 2018 | 180 | 2018 |
| Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease D Alcolea, P Martínez-Lage, P Sánchez-Juan, J Olazarán, C Antúnez, ... Neurology 85 (7), 626-633, 2015 | 178 | 2015 |
| Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes N Setó-Salvia, J Clarimón, J Pagonabarraga, B Pascual-Sedano, ... Archives of neurology 68 (3), 359-364, 2011 | 178 | 2011 |
| Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ... JAMA neurology 79 (3), 228-243, 2022 | 167 | 2022 |
Alberto LleoNeurology Department. Hospital Sant Pau. Barcelona.Verificeret mail på santpau.es